Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-08-13
DOI
10.3389/fimmu.2018.01865
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of transforming growth factor β in T helper 17 differentiation
- (2018) Song Zhang IMMUNOLOGY
- Is there a role for IL-17 in the pathogenesis of systemic sclerosis?
- (2018) Carlo Chizzolini et al. IMMUNOLOGY LETTERS
- Targeting TGF-β signaling for the treatment of fibrosis
- (2018) Andrea Hermina Györfi et al. MATRIX BIOLOGY
- Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
- (2017) Debomita Chakraborty et al. Nature Communications
- Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma
- (2017) Swati Bhattacharyya et al. Advances in Wound Care
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- IL-17 in Chronic Inflammation: From Discovery to Targeting
- (2016) Audrey Beringer et al. TRENDS IN MOLECULAR MEDICINE
- Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
- (2015) Lisa M. Rice et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic sclerosis
- (2015) Yannick Allanore et al. Nature Reviews Disease Primers
- Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
- (2014) Ceri A. Fielding et al. IMMUNITY
- Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis
- (2014) Anna Olewicz-Gawlik et al. International Journal of Rheumatic Diseases
- Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
- (2014) Steven O'Reilly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transforming growth factor β—at the centre of systemic sclerosis
- (2014) Robert Lafyatis Nature Reviews Rheumatology
- High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis
- (2014) Paola Adele Lonati et al. PLoS One
- Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis
- (2014) Lucille Desallais et al. ARTHRITIS RESEARCH & THERAPY
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
- (2013) Frank van den Hoogen et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-17A+ Cell Counts Are Increased in Systemic Sclerosis Skin and Their Number Is Inversely Correlated With the Extent of Skin Involvement
- (2013) Marie-Elise Truchetet et al. ARTHRITIS AND RHEUMATISM
- Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts
- (2013) Nicolò Brembilla et al. ARTHRITIS RESEARCH & THERAPY
- Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis
- (2012) Korsa Khan et al. ANNALS OF THE RHEUMATIC DISEASES
- Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts
- (2012) T. Nakashima et al. JOURNAL OF IMMUNOLOGY
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF- 1-Dependent and -Independent Mechanisms
- (2011) S. Mi et al. JOURNAL OF IMMUNOLOGY
- Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease
- (2011) Marie-Elise Truchetet et al. ARTHRITIS RESEARCH & THERAPY
- Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension
- (2010) Eileen Hsu et al. ARTHRITIS AND RHEUMATISM
- Fibrosis and immune dysregulation in systemic sclerosis
- (2010) Carlo Chizzolini et al. AUTOIMMUNITY REVIEWS
- Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
- (2010) Mark S. Wilson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity
- (2009) Jennifer L. Sargent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes
- (2009) Timothy R. D. J. Radstake et al. PLoS One
- Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
- (2009) Pravitt Gourh et al. ARTHRITIS RESEARCH & THERAPY
- Integrins and the activation of latent transforming growth factor β1 – An intimate relationship
- (2008) P WIPFF et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Clinical association of serum interleukin-17 levels in systemic sclerosis: Is systemic sclerosis a Th17 disease?
- (2008) Maki Murata et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Fibrosis in Systemic Sclerosis
- (2008) John A. Varga et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Pathogenic role of CCL2/MCP-1 in scleroderma
- (2007) Toshiyuki Yamamoto Frontiers in Bioscience-Landmark
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started